DECIPHER SCORE >0.85 IDENTIFIES A VERY HIGH-RISK SUBGROUP WITH ELEVATED RISK OF BIOCHEMICAL RECURRENCE AFTER PROSTATECTOMY.

Author(s)

• RS

  Rohan Sharma, n/a

  Senior Clinical Fellow
  AdventHealth Global Robotics Institute, United States
• MM

  Marcio Covas Moschovas

  Research Coordinator
  AdventHealth Global Robotics Institute
  kissimee, Florida, United States
• SB

  SEETHARAM BHATT, MD

  ASSOCIATE PROFESSOR
  SUNY UPSTATE, New York, United States
• SS

  SHADY SAIKALI, MD

  CLINICAL FELLOW
  ADVENTHEALTH GRI, United States
• 

  YU OZAWA, n/a

  CLINICAL FELLOW
  ADVENTHEALTH GRI, United States
• MS

  MAARCO SANDRI, n/a

  DATA SCIENCE
  UNIV OF BRESICA, Italy
• YF

  YAVUZ FIKRET, n/a

  MS4
  UCF, Florida, United States
• 

  Ahmed Gamal, MD

  Urology Department and Robotic Surgery
  AdventHealth Global Robotics Institute, United States
• TR

  Travis Rogers, n/a

  Robotic Surgeon
  AdventHealth Global Robotics Institute, United States
• 

  Vipul R. Patel, MD

  Urology department and robotic Surgery
  AdventHealth Global Robotics Institute, Florida, United States